Evidence map›Paper›PMID 22969140›Full record

ArticleThe Journal of clinical endocrinology and metabolism2012

Endothelial function is impaired across the stages of the menopause transition in healthy women.

Kerrie L Moreau, Kerry L Hildreth, Amie L Meditz, Kevin D Deane, Wendy M Kohrt

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 169 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 8 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00608062 nacompletednot on this map

Biological Mechanisms of Arterial Stiffening With Age and Estrogen Deficiency

TypeinterventionalSponsorUniversity of Colorado, DenverRan2007 to 2012Enrolled155ConditionsArterial Stiffening, Aging, MenopauseArmsGnRHant - Ganirelix acetate, Transdermal estradiol patch, Transdermal placebo patch
NCT03236545 nacompletednot on this mapstarted 2016, after this paper: background citation

Mechanisms of Vascular Dysfunction in Women: Role of Estradiol

TypeinterventionalSponsorUniversity of DelawareRan2016 to 2022Enrolled48ConditionsCardiovascular Risk FactorArmsNo to Low Endogenous Estrogen, Estradiol
3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 8 syntheses or guidelines pooled it, 324 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Sex differences in endothelial function in chronic kidney disease.American journal of physiology. Renal physiology · 2020
    Trial
  18. Trial
  19. Trial
  20. Trial

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kerrie L MoreauDivision of Geriatric Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, USA. kerrie.moreau@ucdenver.edu
Kerry L Hildreth
Amie L Meditz
Kevin D Deane
Wendy M Kohrt
The Medical Center of Aurora · USInfectious Disease Consultants · USUniversity of Colorado Anschutz Medical Campus · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI MAIER, LISA A · 1985 to 2008
$52.6M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Paul S. Maclean · 1995 to 2026
$32.6M
Biological Mechanisms of Arterial Stiffening With Age and Estrogen DeficiencyR01AG027678 · NIA · UNIVERSITY OF COLORADO DENVER · PI MOREAU, KERRIE · 2006 to 2010
$1.5M
HRT and Exercise Effects on Central Arterial ComplianceK01AG020683 · NIA · UNIVERSITY OF COLORADO DENVER · PI MOREAU, KERRIE · 2002 to 2006
$612k
NCRR NIH HHS M01 RR000051NCRR NIH HHS RR-00051NCRR NIH HHS RR-025780NCRR NIH HHS UL1 RR025780NIA NIH HHS AG027678NIA NIH HHS AG20683NIA NIH HHS K01 AG020683NIA NIH HHS R01 AG027678NIDDK NIH HHS P30 DK048520
6 · The paper itself

Abstract

contextThe stages of the menopause transition are characterized by changes in ovarian hormones and increased cardiovascular disease (CVD) risk factors and vasomotor symptoms that may adversely affect vascular health.

objectiveWe tested the hypothesis that endothelial function, a predictor of CVD, would be reduced across the stages of the menopause transition, independent of CVD risk factors and vasomotor symptoms. DESIGN, SETTING, AND

participantsThis was a cross-sectional study of 132 healthy women from the general community aged 22-70 yr, categorized as premenopausal (n = 33, 32 ± 6 yr; mean ± SD), early perimenopausal (n = 20, 49 ± 3 yr) or late perimenopausal (n = 22, 50 ± 4 yr), or early (n = 30, 55 ± 3 yr) or late postmenopausal (n = 27, 61 ± 4 yr). MAIN OUTCOME: Endothelial-dependent vasodilation was measured by brachial artery flow-mediated dilation (FMD) using ultrasound.

resultsBrachial artery FMD was significantly different among the groups (P < 0.001). It was highest in premenopausal women (9.9 ± 2.1%) with progressive decrements in perimenopausal (early: 8.2 ± 2.5%; late: 6.5 ± 1.9%) and postmenopausal women (early: 5.5 ± 1.9%; late: 4.7 ± 1.7%). Adjustment for risk factors, vasomotor symptoms, and sex hormones did not alter the association (P < 0.001). In subgroup analyses of women aged 50-59 yr, brachial artery FMD was lower in late peri- and early and late postmenopausal compared with early perimenopausal women (P < 0.001) but was not different between late perimenopausal and either early or late postmenopausal women.

conclusionsOur findings suggest that a decline in endothelial function begins during the early stages of menopause (perimenopause) and worsens with the loss of ovarian function and prolonged estrogen deficiency. These data add to the accumulating evidence that the perimenopausal window is a critical time period for adverse changes in CVD risk.

Indexed as

HealthAdultAgedBrachial ArteryCardiovascular DiseasesCohort StudiesCross-Sectional StudiesEndothelium, VascularFemaleHumansMenopauseMiddle AgedRisk FactorsUltrasonographyVasodilationWomen's Health

Identifiers

PMID22969140
PMCPMC3513538
OpenAlexW2015177574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.